Informaciones
Psiquiátricas
2015 - n.º 220
51
A randomized, double-blind, placebo-
controlled study of aripiprazole for the
treatment of psychosis in nursing home
patients with Alzheimer disease. Am J
Geriatr Psychiatry. 2008 Jul;16(7):537-
50.
20. Suzuki H, Gen K, Inoue Y, Hibino H,
Mikami A, Matsumoto H, et al. The in-
fluence of switching from risperidone
to paliperidone on the extrapyramidal
symptoms and cognitive function in
elderly patients with schizophrenia: A
preliminary open-label trial. Int J Psy-
chiatry Clin Pract. 2014 Jan;18(1):58-
62
21. Suzuki H, Gen K, Otomo M, Inoue Y, Hi-
bino H, Mikami A, et al. Study of the
efficacy and safety of switching from
risperidone to paliperidone in elderly
patients with schizophrenia. Psychiatry
Clin Neurosci. 2013 Feb;67(2):76-82.
doi: 10.1111/pcn.12026.
22. Suzuki H, Gen K, Otomo M, Inoue Y, Hi-
bino H, Mikami A, Matsumoto H, Mika-
mi K. Relationship between the plasma
concentration of paliperidone and the
clinical and drug-induced extrapyrami-
dal symptoms in elderly patients with
schizophrenia.
23. Suzuki Y, Fukui N, Watanabe J, Ono S, Su-
gai T, Tsuneyama N, et al. QT prolongation
of the antipsychotic risperidone is predo-
minantly related to its 9-hydroxy metabo-
litepaliperidone. Hum Psychopharmacol.
2012 Jan;27(1):39-42. doi: 10.1002/
hup.1258. Epub 2011 Dec 5.
24. Bishara D, Taylor D. Adverse effects of
clozapine in older patients: epidemiolo-
gy, prevention and management. Drugs
Aging. 2014 Jan;31(1):11-20. doi:
10.1007/s40266-013-0144-2. Review.
25. Sikirica S, Marino M, Gagne JJ, De Pal-
ma R, Maio V. Risk of death associated
with the use of conventional vs. aty-
pical antipsychotic medications: eva-
luating the use of the Emilia-Romagna
Region database for pharmacoepide-
miological studies. J Clin Pharm Ther.
2014 Feb;39(1):38-44. doi: 10.1111/
jcpt.12099. Epub 2013 Sep 16.
26. Vasilyeva I, Biscontri RG, Enns MW,
Metge CJ, Alessi-Severini S. Adverse
events in elderly users of antipsycho-
tic pharmacotherapy in the provin-
ce of Manitoba: a retrospective co-
hort study. J Clin Psychopharmacol.
2013 Feb;33(1):24-30. doi: 10.1097/
JCP.0b013e31827934a4.
27. Gerhard T, Huybrechts K, Olfson M, Sch-
neeweiss S, Bobo WV, Doraiswamy PM,
et al. Comparative mortality risks of an-
tipsychotic medications in community-
dwelling older adults. Br J Psychiatry.
2014 Jul;205(1):44-51. doi: 10.1192/
bjp.bp.112.122499. Epub 2013 Aug 8.
28. Zheng L, Mack WJ, Dagerman KS, Hsiao
JK, Lebowitz BD, Lyketsos CG, et al.
Metabolic changes associated with
second-generation antipsychotic use
in Alzheimer`s disease patients: the
CATIE-AD study. Am J Psychiatry. 2009
May;166(5):583-90.
29. Langballe EM, Engdahl B, Nordeng H, Ba-
llard C, Aarsland D, Selbæk G. Short- and
long-term mortality risk associated with
the use of antipsychotics among 26,940
COMORBILIDAD MÉDICA Y CRITERIOS DE USO DE ANTIPSICÓTICOS EN ANCIANOS
